Successful Conversion from Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients

OBJECTIVE: The management of hyperparathyroidism in hemodialysis patients involves the administration of phosphate binders, vitamin D receptor activators and calcimimetics. Intravenous paricalcitol has been preferred over oral calcitriol as it may cause less hypercalcemia and hyperphosphatemia. Howe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Ren Nutr
Egile Nagusiak: Kumar, Jennifer, Tran, Ngoc-Tram Gia, Schomberg, John, Streja, Elani, Kalantar-Zadeh, Kamyar, Pahl, Madeleine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4912884/
https://ncbi.nlm.nih.gov/pubmed/27038806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.jrn.2016.02.006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak